Terms of Reference
The Review Committee
A Review Committee will be created with a group of experts and a chair. The committee will comprise suitably qualified experts selected by the chair and Lifeblood aims to retain as many original members of the 2012 review as possible.
What the Committee will do
- Review relevant local and international developments since the conclusion of the 2012 review in relation to deferring donors on the basis of current and/or past sexual activity.
- Considering above in the context of ensuring the ongoing safety of blood and blood products provided in Australia, re-evaluate the recommendations of the 2012 review.
Areas of Emphasis
Particular emphasis should be placed on:
- Whether the 2012 review’s recommended deferral period of 6 months for men who have sex with men (MSM) remains appropriate, or whether a different minimum period of deferral is justified based on current evidence.
- Whether it is possible to consistently identify a set of criteria by which individuals might be identified as at greater risk of acquiring blood borne infections than that of the wider population.
- Whether plasma for fractionation (which is subject to targeted pathogen inactivation during processing) provides an opportunity to expand donation by MSM without affecting recipient safety.
- Whether the level of protection afforded by regular condom use and HIV pre-exposure prophylaxis (PrEP) alone or in combination is sufficient to avoid exclusion. If not, whether the risk is changed such that the deferral period could be adjusted.
- Considering developments since the 2012 review, the appropriateness of excluding current and former sex workers and the appropriate period of any deferral.
What the Committee will address:
In developing its recommendations the Review Committee will take into account:
- Compliance with Australian legislation (Commonwealth, State and Territory), especially anti-discriminatory.
- The obligation of Lifeblood to ensure that the blood and blood products provided to patients are as safe as reasonably achievable.
- Regulations which oblige Lifeblood to conform to mandatory and non mandatory recognised international standards.
- Ethical issues affecting both potential donors and recipients of blood and blood products.
- The practicalities of implementing any recommendations in the ongoing operations of Lifeblood.